February 1, 2012
Skin-cancer drug tested in Valley approved
The Food and Drug Administration’s approval of a new drug studied in the Valley gives hope to patients with a type of advanced skin cancer — patients who, until now, had no other treatment options. The approval also marks the first time that a drug has received a federal green light after clinical trials performed […]
Tags: Dr. Aleksander Sekuliclater, oncology research, Scottsdale Healthcare, skin cancer, Translational Genomics Research Institute